Form D — Somite Therapeutics, Inc.
0001231919-25-000557 · filed 2025-11-26
Offering
- Industry
- Other
- Exemptions
- 06b
- Total offering
- $47,499,943
- Total sold
- $47,499,943
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Somite Therapeutics, Inc.
- CIK
- 2075078
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 40 GUEST STREET
BOSTON, MA 02135 - Phone
- 512-270-9113
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Micah Breakstone · Executive OfficerBOSTON, MA Find on LinkedIn ↗
-
Chad Cowan · DirectorBOSTON, MA Find on LinkedIn ↗
-
Steven Holtzman · DirectorBOSTON, MA Find on LinkedIn ↗
View original on SEC EDGAR.